Detalles de la búsqueda
1.
Immune response after two doses of the BNT162b2 COVID-19 vaccine and risk of SARS-CoV-2 breakthrough infection in Tyrol, Austria: an open-label, observational phase 4 trial.
Lancet Microbe
; 4(8): e612-e621, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37354911
2.
Six-Month Follow-Up of Immune Responses after a Rapid Mass Vaccination against SARS-CoV-2 with BNT162b2 in the District of Schwaz/Austria.
Viruses
; 14(8)2022 07 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36016265
3.
Heterologous ChAdOx1/BNT162b2 vaccination induces stronger immune response than homologous ChAdOx1 vaccination: The pragmatic, multi-center, three-arm, partially randomized HEVACC trial.
EBioMedicine
; 80: 104073, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35617826
4.
BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants.
Nat Commun
; 13(1): 7701, 2022 12 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36513653
5.
Seroprevalence of SARS-CoV-2 infection in the Tyrolean district of Schwaz at the time of the rapid mass vaccination in March 2021 following B.1.351-variant outbreak.
Front Public Health
; 10: 989337, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36159252
6.
High Prevalence of Undocumented SARS-CoV-2 Infections in the Pediatric Population of the Tyrolean District of Schwaz.
Viruses
; 14(10)2022 10 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-36298849
Resultados
1 -
6
de 6
1
Próxima >
>>